Exploring the landscape of synthetic IL‐6‐type cytokines

Abstract

Interleukin‐6 (IL‐6)‐type cytokines not only have key immunomodulatory functions that affect the pathogenesis of diseases such as autoimmune diseases, chronic inflammatory conditions, and cancer, but also fulfill important homeostatic tasks. Even though the pro‐inflammatory arm has hindered the development of therapeutics based on natural‐like IL‐6‐type cytokines to date, current synthetic trends might pave the way to overcome these limitations and eventually lead to immune‐inert designer cytokines to aid type 2 diabetes and brain injuries. Those synthetic biology approaches include mutations, fusion proteins, and inter‐cytokine swapping, and resulted in IL‐6‐type cytokines with altered receptor affinities, extended target cell profiles, and targeting of non‐natural cytokine receptor complexes. Here, we survey synthetic cytokine developments within the IL‐6‐type cytokine family and discuss potential clinical applications.